PAI
Pittenger & Anderson Inc’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,748
| Closed | -$150K | – | 447 |
|
|
2022
Q1 | $150K | Buy |
+2,748
| New | +$150K | 0.01% | 228 |
|
|
2021
Q1 | – | Sell |
-46,400
| Closed | -$2.13M | – | 401 |
|
|
2020
Q4 | $2.13M | Hold |
46,400
| – | – | 0.12% | 142 |
|
|
2020
Q3 | $2.18M | Hold |
46,400
| – | – | 0.14% | 139 |
|
|
2020
Q2 | $2.37M | Buy |
46,400
+6,260
| +16% | +$319K | 0.17% | 125 |
|
|
2020
Q1 | $1.9M | Sell |
40,140
-58
| -0.1% | -$2.75K | 0.16% | 125 |
|
|
2019
Q4 | $2.36M | Buy |
40,198
+340
| +0.9% | +$20K | 0.16% | 138 |
|
|
2019
Q3 | $2.13M | Hold |
39,858
| – | – | 0.15% | 144 |
|
|
2019
Q2 | $1.99M | Buy |
39,858
+1,800
| +5% | +$90.1K | 0.15% | 145 |
|
|
2019
Q1 | $1.99M | Buy |
38,058
+5,200
| +16% | +$272K | 0.16% | 145 |
|
|
2018
Q4 | $1.57M | Buy |
32,858
+58
| +0.2% | +$2.77K | 0.14% | 149 |
|
|
2018
Q3 | $1.65M | Hold |
32,800
| – | – | 0.13% | 152 |
|
|
2018
Q2 | $1.65M | Hold |
32,800
| – | – | 0.14% | 148 |
|
|
2018
Q1 | $1.6M | Buy |
+32,800
| New | +$1.6M | 0.14% | 154 |
|
|
2017
Q1 | – | Sell |
-80
| Closed | -$4K | – | 347 |
|
|
2016
Q4 | $4K | Sell |
80
-24
| -23% | -$1.2K | ﹤0.01% | 355 |
|
|
2016
Q3 | $6K | Hold |
104
| – | – | ﹤0.01% | 339 |
|
|
2016
Q2 | $6K | Sell |
104
-13,320
| -99% | -$768K | ﹤0.01% | 346 |
|
|
2016
Q1 | $680K | Hold |
13,424
| – | – | 0.08% | 174 |
|
|
2015
Q4 | $677K | Sell |
13,424
-296
| -2% | -$14.9K | 0.08% | 171 |
|
|
2015
Q3 | $659K | Hold |
13,720
| – | – | 0.09% | 178 |
|
|
2015
Q2 | $714K | Hold |
13,720
| – | – | 0.09% | 184 |
|
|
2015
Q1 | $791K | Buy |
13,720
+13,400
| +4,188% | +$773K | 0.1% | 173 |
|
|
2014
Q4 | $17K | Hold |
320
| – | – | ﹤0.01% | 360 |
|
|
2014
Q3 | $18K | Hold |
320
| – | – | ﹤0.01% | 332 |
|
|
2014
Q2 | $21K | Buy |
+320
| New | +$21K | ﹤0.01% | 337 |
|